title: [A Case of Rectal Cancer with Lymphangiosis Carcinomatosa Successfully Treated with Chemotherapy Despite Anaphylactic Reaction to Oxaliplatin].
abstract: A 64-year-old man was admitted because of dyspnea. He was diagnosed with rectal cancer with lymphangiosis carcinomatosa and metastases in the liver and lymph nodes. The patient was treated with cetuximab and modified FOLFOX6 (mFOLFOX6). After treatment, the primary rectal cancer and metastases were considered to have achieved a partial response (PR) and the lymphangiosis carcinomatosa remarkably improved. However, anaphylactic shock occurred in the 6 courses of treatment, 5 minutes after the infusion of oxaliplatin, and the patient was treated.
authors.affiliation: Dept. of Surgery, Oita Prefecture Saiseikai Hita Hospital.
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Ozaki
authors.forename: Ryouzou
authors.initials: R
authors.lastname: Hayashida
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Nishi
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Ishibashi
authors.forename: Kanako
authors.initials: K
authors.lastname: Sakurai
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Nishimura
authors.forename: Yoshito
authors.initials: Y
authors.lastname: Akagi
mesh_terms: D000707:Anaphylaxis / Q000139:chemically induced*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008205:Lymphangitis / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077150:Oxaliplatin; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin